Uncategorized

Polyneuropathy with Anti-sulfatide and Anti-MAG Antibodies: Clinical, Neurophysiological, Pathological Features and Response to Treatment

Anti-MAG Autoantibodies ELISA Citation: Campagnolo M et al.; Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. J Neuroimmunol. 2015 Apr 15; 281:1-4. PMID:25867460

Read more

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies

Anti-MAG Autoantibodies ELISA Citation: Magy L et al.; Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies; J Immunol Res. 2015;2015: 450391. doi: 10.1155/2015/450391. Epub 2015 May 6. PMID:26065001

Read more

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Fcγ receptor IIIA genotype is associated with rituximab response in anti-myelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8): 918-20.PMID:24487381

Read more

Long-term Efficacy of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Neuropathy: RIMAG Follow-up Study; Journal of the Peripheral Nervous System

Anti-MAG Autoantibodies ELISA Citation: Ferfoglia R I et al.; Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study; Journal of the Peripheral Nervous System 21:10–14 (2016)PMID:26748872

Read more